On January 28, Walmart announced an expansion of its healthcare offerings, adding clinical research sites this spring in an initial rollout across 10 existing stores and three former clinic locations. The company is also increasing its pharmacy workforce by 15%, bringing total pharmacy staff to more than 20,000 nationwide. By integrating services such as basic diagnostics, prescription management and patient enrollment for clinical trials, Walmart aims to leverage its 4,700-store footprint to capture a share of the $4.3 trillion U.S. healthcare market while boosting average transaction frequency among its core customer base.

Under CEO Doug McMillon’s leadership, Walmart has transformed into a seamless multi-platform retailer, integrating curbside pickup, home delivery and an expanded online assortment. Internal surveys conducted in Q4 2025 show that convenience now rates within two percentage points of price as the primary driver of store preference among households earning over $100,000 annually. Over the past two years, Walmart’s e-commerce sales have grown at a 25% compound annual rate, helping the company capture approximately 10% of total U.S. grocery e-commerce spend.

After more than 40 years with the retailer and nearly 12 years as CEO, Doug McMillon will retire on January 31, 2026. During his tenure, Walmart’s market capitalization rose from approximately $200 billion to over $450 billion, driven by investments in logistics automation, digital capabilities and new service lines. Incoming CEO John Furner faces the task of sustaining growth in higher-margin categories—particularly healthcare and media partnerships such as the recently announced MLS co-branded broadcasts—while maintaining Walmart’s leadership in value retailing.